Back to Search Start Over

Hepatotoxicity induced by coxibs: how concerned should we be?

Authors :
Raúl J. Andrade
Fernando Bessone
Marcelo G. Roma
Mercedes Robles-Díaz
Manuel Mendizabal
Nelia Hernández
Ezequiel Ridruejo
Inmaculada Medina-Caliz
M. Isabel Lucena
Source :
Expert Opinion on Drug Safety. 15:1463-1475
Publication Year :
2016
Publisher :
Informa UK Limited, 2016.

Abstract

Introduction: The selective inhibitors of COX-2, coxibs, are nonsteroidal anti-inflammatory drugs (NSAIDs) that have much better gastrointestinal safety profile as compared with non-selective NSAIDs. In this review, we analyze both the epidemiological features of coxib-induced hepatotoxicity and the clinical impact of coxib-associated liver damage, based on literature data. Areas covered: We carried out a search of the databases MEDLINE (PubMed), LILACS and SCIELO, from December 1999 to January 2016, to retrieve studies exploring the real impact of coxibs in liver toxicity as compared to non-selective COX-2 inhibitor NSAIDs. Expert opinion: Although reliable data on the incidence of celecoxib- and etoricoxib-induced hepatotoxicity are lacking, because of cohort studies have been generally underpowered to detect hepatic events, coxibs have been scarcely related to hepatotoxicity. Hence, coxib-induced liver injury seems to be an uncommon event, yet exhibits a wide spectrum of damage. Increasing COX-2 drug selectivity, as for rofecoxib, valdecoxib, parecoxib, and lumiracoxib, has been associated with higher cardiovascular risk, as well as dermatological and serious hepatic reactions. The actual risk of liver toxicity from the currently approved coxibs compared with non-selective NSAIDs will be discussed. Finally, classical and novel molecular mechanisms of coxib-induced hepatotoxicity are also described. Fil: Bessone, Fernando. Provincia de Santa Fe. Ministerio de Salud y Medio Ambiente - Rosario. Hospital Provincial del Centenario; Argentina Fil: Hernandez, Nelia. Universidad de la República; Uruguay Fil: Roma, Marcelo Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Fisiología Experimental. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Fisiología Experimental; Argentina Fil: Ridruejo, Ezequiel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno”; Argentina Fil: Mendizabal, Manuel. Hospital Universitario Austral; Argentina Fil: Medina Cáliz, Inmaculada. Universidad de Málaga; España Fil: Robles Díaz, Mercedes. Universidad de Málaga; España Fil: Lucena, M. Isabel. Universidad de Málaga; España Fil: Andrade, Raúl J.. Universidad de Málaga; España

Details

ISSN :
1744764X and 14740338
Volume :
15
Database :
OpenAIRE
Journal :
Expert Opinion on Drug Safety
Accession number :
edsair.doi.dedup.....5350b055af405f8fa9442dcfa7dff92b